<?xml version="1.0" encoding="UTF-8" ?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">


<journal>
<language>en</language>
<journal_id_issn>1726-7536</journal_id_issn>
<journal_id_issn_online>1735-8507</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi></journal_id_doi>
<journal_id_isnet></journal_id_isnet>
<journal_id_iranmedex>69</journal_id_iranmedex>
<journal_id_magiran>2139</journal_id_magiran>
<journal_id_sid>288</journal_id_sid>
<pubdate PubStatus="epublish">
	<type>gregorian</type>
	<year>2020</year>
	<month>3</month>
	<day>17</day>
</pubdate>
<volume>21</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>32500016</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>Prediction of Gestational Diabetes by Measuring the Levels of Pregnancy Associated Plasma Protein-A (PAPP-A) During Gestation Weeks 11-14</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;Background: The present study aimed to determine the association between pregnancy-associated plasma protein A (PAPP-A) and Gestational Diabetes Methods (GDM) to detect a risk factor for predicting GDM at gestational weeks 11-14.&lt;br /&gt;
Methods: This analytical prospective study recruited 284 pregnant women presenting to six healthcare centers of Qazvin, Iran from February to December 2016. PAPP-A was measured at gestational weeks 11-14 and glucose tolerance test was conducted at gestational weeks 24-28. The participants were assigned into two groups of exposure (reduced PAPP-A) and non-exposure (normal PAPP-A). The association between GDM and PAPP-A was studied. The number of women in exposure group were 201 and 83 in the non-exposure group. Differences between groups were assessed by the Mann&amp;ndash;Whitney, Chi-square, T test, logistic regression analysis and ROC Curve with a significance level of 0.05.&amp;nbsp;&lt;br /&gt;
Results: Twenty eight (33.73%) patients of the exposure group and 17 (8.46%) of non-exposure group developed GDM. There was a significant difference between the two groups in terms of GDM (p&amp;lt;0.001) and the risk of GDM was 3.98 fold higher in the exposure group (reduced PAPPA &lt;em&gt;mu/L&lt;/em&gt;) than that of the non-exposure group (CI=2.39-6.65, p&amp;lt;0.001). Also, 53.3% of the exposure group and 46.7% of the non-exposure group were diagnosed with GDM (p=0.02). There was a significant difference in GDM between the groups and the risk of GDM was 1.85 times higher in the exposure group (reduced PAPPA MOM) than that in the control group (CI=1.09-3.15, p=0.020). According to the ROC curve results, PAPP-A and MOM are acceptable indicators for predicting GDM.&lt;br /&gt;
Conclusion: A low PAPP-A level (MOM, MU/L) as a new risk factor for GDM can help early prediction and prevent maternal and fetal complication by timely treatment.&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Gestational diabetes, Pregnancies, Pregnancy associated plasma protein A</keyword>
	<start_page>130</start_page>
	<end_page>138</end_page>
	<web_url>https://www.jri.ir/article/60076</web_url>
	<pdf_url>https://www.jri.ir/documents/fullpaper/en/60076.pdf</pdf_url>
	<author_list><author><first_name>Somayeh</first_name><middle_name></middle_name><last_name>Ramezani</last_name><suffix></suffix><affiliation>Student Research Committee, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>62030</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Mahboubeh</first_name><middle_name></middle_name><last_name>Ahmadi Doulabi</last_name><suffix></suffix><affiliation>Midwifery and Reproductive Health Research Center, Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email>mah1372@yahoo.com</email><code>62029</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Hamid</first_name><middle_name></middle_name><last_name>Saqhafi</last_name><suffix></suffix><affiliation>School of Paramedical Sciences, Qazvin University of Medical Sciences, Qazvin, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>62031</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Mahmood</first_name><middle_name></middle_name><last_name>Alipoor</last_name><suffix></suffix><affiliation>Department of Biostatistics, Faculty of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>62032</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

</articleset>
</journal>

